Cargando…
Current status and issues with the dosimetric assay of iodine-125 seed sources at medical facilities in Japan: a questionnaire-based survey
In conducting dosimetric assays of seed sources containing iodine-125 ((125)I), several major guidelines require the medical physicist to verify the source strength before patient treatment. Japanese guidelines do not mandate dosimetric assays at medical facilities, but since 2017, three incidents h...
Autores principales: | Kojima, Toru, Kawamura, Shinji, Otani, Yuki, Hanada, Takashi, Wakitani, Yuichiro, Naniwa, Kenta, Yorozu, Atsunori, Ikushima, Hitoshi, Dokiya, Takushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665308/ https://www.ncbi.nlm.nih.gov/pubmed/37697653 http://dx.doi.org/10.1093/jrr/rrad063 |
Ejemplares similares
-
Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study
por: Nakano, Masahiro, et al.
Publicado: (2015) -
Source strength assay of iodine‐125 seeds sealed within sterile packaging
por: Otani, Yuki, et al.
Publicado: (2013) -
Evaluation of dose perturbations around iodine-125 seed sources in supplemental external beam prostate radiotherapy
por: Kanda, Daisuke, et al.
Publicado: (2023) -
Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial
por: Konaka, Hiroyuki, et al.
Publicado: (2012) -
Stenting of the Portal Vein Combined with Different Numbers of Iodine-125 Seed Strands: Dosimetric Analyses
por: Yao, Li-Hong, et al.
Publicado: (2017)